
Attruby: Uses, Dosage, Side Effects, Warnings - Drugs.com
Nov 25, 2024 · Attruby (acoramidis) is an oral prescription medicine used to treat heart problems due to cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM).
ATTR-CM Treatment Option - Attruby™ (acoramidis)
What is Attruby ® (acoramidis)? Attruby is a prescription medicine used to treat adults with a disease that affects the heart muscle called cardiomyopathy of wild-type or variant transthyretin-mediated …
What to Know About Attruby for Transthyretin Amyloid ... - WebMD
Jul 29, 2025 · Attruby binds to the TTR protein and stabilizes it. This helps prevent it from folding the wrong way or from unfolding, which helps lower the chance of the body forming new clumps over time.
Attruby: Cost, Dosage, Side Effects, Uses, Interactions, and More
Feb 5, 2026 · Learn about cost, uses, and more of Attruby (acoramidis), which is a prescription tablet that treats transthyretin amyloid cardiomyopathy (ATTR-CM) in adults.
ATTRUBY is a prescription medicine used to treat adults with a disease that affects the heart muscle called cardiomyopathy of wild-type or variant transthyretin-mediated amyloidosis (ATTR-CM), to...
ATTRUBY™ - PANTHERx Rare
Attruby is a transthyretin stabilizer indicated for the treatment of the cardiomyopathy of wild-type or variant transthyretin-mediated amyloidosis (ATTR-CM) in adults to reduce cardiovascular death and …
Acoramidis - Wikipedia
Acoramidis, sold under the brand name Attruby, is a medication used for the treatment of cardiomyopathy. [1] It is a near-complete (>90%) transthyretin stabilizer, developed to mimic the …
- [PDF]
Attruby™ (acoramidi
midis) What is Attruby? Attruby is a TTR stabilizer developed for treating patients with transthyretin amyloidosis (ATTR) who have heart invol. ement (cardiomyopathy). ATTR is caused by the …
Attruby (Acoramidis Tablets): Side Effects, Uses, Dosage ...
Dec 16, 2024 · Attruby (acoramidis) is a transthyretin stabilizer indicated for the treatment of the cardiomyopathy of wild-type or variant transthyretin-mediated amyloidosis (ATTR-CM) in adults to …
Drug Trials Snapshot: ATTRUBY | FDA
Jan 14, 2025 · ATTRUBY is a transthyretin stabilizer that is indicated for the treatment of the cardiomyopathy of wild-type or variant transthyretin-mediated amyloidosis (ATTR-CM) in adults to …